Lai, Timothy Y Y <br/><br/>
Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)  Sep 2011 
 - 1581-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1539-2864 
<br/><br/><label>Standard No.: </label>10.1097/IAE.0b013e31820d3f3f  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Choroid--blood supply<br/>Choroid Diseases--diagnosis<br/>Coloring Agents<br/>Combined Modality Therapy<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Humans<br/>Indocyanine Green<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Peripheral Vascular Diseases--diagnosis<br/>Photochemotherapy<br/>Ranibizumab<br/>Retrospective Studies<br/>Treatment Outcome<br/>Visual Acuity--physiology